Printer Friendly

Articles from Chain Drug Review (April 23, 2007)

1-243 out of 243 article(s)
Title Author Type Words
'Caring for you and about you'. Brief article 277
'Free 30' program touts generics. Brief article 298
'No pay co-pay' initiative promotes generics use. Brief article 253
'One of our core values is to be a caring neighbor'. Brief article 210
'Pathways to pharmacy' created by CVS/Caremark. 360
A first for Walgreens' IsaDora line. Brief article 287
A lot is riding on definition of AMP. 575
A pivotal figure passes from the scene. Brief article 311
A primer on prospects for some industry heavyweights: the effectiveness of R&D efforts is the key to the success of branded pharmaceutical makers. 4452
A reinvigorated NACDS goes to bat for community Rx. 681
Actavis to launch ranitidine syrup. 320
Adapting to the digital revolution. 173
Addition of Caremark makes CVS titan in PBM realm. 510
Adventrx and TRx register brand. Brief article 154
Aggressive marketing, push produces intended results. 342
Aggressive steps taken to build pharmacy business. Company overview 658
Alberta grants some prescribing power. Brief article 245
Anderson on his approach to managing NACDS. Interview 4834
APhA pushes pharmacists' role. Schultz, John 538
As Canadian market changes, Peoples thrives. Company overview 572
At Lawtons, pharmacy always comes first. 665
Auburn faculty aims to clarify role. 705
Aurora provides integrated care. Company overview 710
Bartell always maintains focus. 641
Battle among trade classes for share in prescription drug arena intensifies. 385
Bernauer on the present and future of pharmacy. Interview 4951
Big A offers shoppers 'low prices every day'. Company overview 720
Big drug chains master the art, science of technology. 1029
BIO sets stage for big show. Conference notes 452
BioScrip an expert in specialty Rx. Company overview 582
Biotech revolution creates challenges, opportunities. 378
Blister Block joins J&J's Band-Aid line. Brief article 139
Blood pressure monitor from A&D wins award. Brief article 187
Bodine, Merlo chosen to head new divisions. 451
Building mail-order Rx business a priority for PBM unit. 671
Calls for change continue as Medicare part d settles in. 661
Campanelli to head Par generics division. 406
Can VA plan be used as a model? Brief article 278
Canadians could benefit from more use of generics. Brief article 249
CE catalog highlights. 417
Chain drug store operators remain on fast growth track. Industry overview 1247
Charitable efforts are high on list of priorities. 367
Cloud over drug companies lifts. 705
CMS moves to assist poor. Brief article 174
CMS postpones implementation of AMP. Brief article 241
CMS projects big surge in drug spending. 414
Combos are potent force in pharmacy. 316
Communication with customers essential. 542
Company founder is honored as visionary. 508
Company poised to top 1,000th drug store mark. Brief article 257
Compensation model shows signs of change. Coopman, Robert 606
Congress eyes PDUFA renewal. 580
Consumers like in-store health clinics. Brief article 212
Coutu turns attention to Canada. 1077
CVS a proven master at art of assimilation. 529
CVS agrees to buy Albertsons' drug stores. Brief article 278
CVS agrees to merge with Caremark Rx. Brief article 193
CVS alters pharmacy paradigm. Company overview 1016
CVS gets into walk-in health clinic business. Brief article 245
CVS succeeds in making itself a beauty destination. 543
Deal facilitates 'unqiue solutions'. Company overview 511
Del broadens reach of Sally Hansen brand. 445
Demographic trends bode well for community pharmacy. Brief article 297
Dems move health care to top of agenda. Brief article 237
Development of MTM is under way. 381
Dial is rolling out RGX Bodyspray. Brief article 178
Differentiation is goal throughout the store. 485
Discount Drug Mart hones niche. Company overview 917
Discount store operators find new avenues of growth. Statistical data 1249
Discounted pricing on select generics shakes things up. 594
Dollar General buy affirms status of extreme-value chains. 1139
Downey to remain GPhA chair. 375
Drug benefit reform moves to top of agenda. 549
Duane Reade closes books on year of solid progress. Financial report 1937
Duane Reade eyes past accounting. 473
Duane Reade moves to 'fix, maximize, grow'. Brief article 259
Duane Reade puts house in order. Company overview 1801
E-prescribing revolution is here. 474
Elephant plans to improve results at existing stores, expand. 778
Exclusive brands help set the retailer apart. Brief article 369
Execs are undaunted by fierce competition. Brief article 194
Executive changes facilitate new programs. 609
Exit from board marks end of era. 356
Express Scripts starts battle for Caremark. Brief article 235
Fagen learns to cope with Part D. Company overview 510
Family Dollar works to increase relevance to customer base. 738
Farmacias El Amal expands capabilities. Company overview 486
FDA moves to raise confidence in advisory committees. 654
File buys help fuel Rx growth. Brief article 273
For drug chains, wellness should mean more than Rx. Liebmann, Wendy 1114
Forging links in health care. 602
Format embraces high-turn items. 287
Fruth puts premium on efficiency. Company overview 722
Fuller era comes to abrupt end at NACDS. Brief article 223
Generics dispensing soon to exceed 60%. 445
Generics' rise benefits retailers. Brief article 327
Giving shoppers what they want. Report 554
Global Rx soles grow 7% in '06. 727
GNC alliance provides an edge. 443
Goal is to be 'right in beauty care'. Brief article 238
GSK unveils more convenient form of Coreg, targets oncology. Brief article 268
Hannah again steps into breach at NACDS. Brief article 259
Happy Harry's is acquired by Walgreens. Brief article 253
Hartig makes investments in diverse aspects of operation. Company overview 811
Health Mart has the momentum. Company overview 642
Heritage adds to offerings. Brief article 209
Hi-School finds the right formula. Company overview 553
Hopes high as Anderson era starts at NACDS. Pinto, David 641
House rejects more Medicaid cuts. 613
Hy-Vee gets results at front end. Company overview 977
Hypnion will be acquired By Eli Lilly. Brief article 245
Improved business model pays off for Financial report 775
Improved logistics a byproduct of Albertsons acquisition. 489
In-store clinics become part of landscape. 551
In-store health clinics are added to the mix. 354
Industry holds its own in rocky financial markets. 348
Industry succeeds in having voice heard. Brief article 226
Innovative store concept bows. Brief article 224
Insights on treating diabetes. Rubino, Peter 462
Integration of Osco, Sav-on into CVS begins. Brief article 233
Integration team gets out of blocks quickly. Company overview 700
Interest rates likely to stay steady. Brief article 226
Investment to speed up expansion. Brief article 168
Investors remain bullish about drug store stocks. 815
Janumet wins O.K. from FDA. Brief article 176
Jewel-Osco teams up with Destiny Health. 321
Katz commitment to Rx care embodied in stores. Company overview 847
Kerr stakes its reputation on pharmacy, health care. Company overview 942
Kinney capitalizes on roots in operating area. Company overview 761
Law impacts drugs for children. Brief article 232
Levin: until his keys don't fit ... he will continue to go in. Walden, Geoff 858
Lewis optimistic despite challenges. Company overview 689
Lilly steps up fight against tuberculosis. 307
Lipitor gets five more indications. Brief article 185
London Drugs good at being in right place at right time. Company overview 1158
Longs gives back to communities. Brief article 297
Longs makes progress on all major fronts. Brief article 267
Longs, Rite Aid agree to swap some outlets. Brief article 262
Loyalty plan will be taken to next level. Brief article 155
Loyalty program connects with customers. Brief article 293
Loyalty program draws shoppers. Brief article 120
Mail-order a thorny issue for retail pharmacy operators. 407
Major transactions reshape retail pharmacy landscape. 901
Marc's changes with the times. Company overview 830
Medicaid cuts create headache for patients, providers. 527
Medicare Part D debut gets mixed reviews. Brief article 237
Medicare Part D rollout is handled efficaciously. Company overview 591
MinuteClinic rollout accelerates. Brief article 385
MSI paves way for franchisees. Company overview 788
Mylan legal victory clears way for intro. Brief article 217
NACDS assesses state of retail pharmacy. Brief article 209
NACDS gears up in order to get word out. 418
Naterra builds skin care collection. 338
Natrol touts time-release supplements. Brief article 280
Navarro is gearing up for expansion drive. Company overview 655
New call for government to negotiate Medicare Rx prices. 563
New CEO takes reins at drug fair. 869
New system targets meth issue. Company overview 517
New ways found to assist associate members. 827
New York market demands flexibility. Brief article 224
NPI numbers to be phased in. 380
OGD under pressure. 484
Opponents dig in as battle over biogenerics intensifies. 679
Organic apparel wins place in mix. Brief article 175
Original hybrid format feels the pressure from rivals. 1080
Other retailers take page from Wal-Mart. Brief article 278
P-O-S systems to go interactive. 989
Parent company sticks to concept. Company overview 517
Patent on Ambien is challenged by Barr. 340
Pharmaca concept strikes chord. Company overview 1096
Pharmacists have newfound appeal. Brief article 213
Pharmacy chains have the strongest hand in Canada. 724
Pharmacy quality alliance goes to work. 378
Pharmacy Won fights for soot in tough Ontario market. 512
Pharmasave gets more efficient. Company overview 1382
PrairieStone aims to show 'one plus one equals three'. 668
Preston named new Pharmaca marketing exec. Brief article 189
Program needs to tighten ship. Brief article 272
Program promotes healthy environment. Brief article 290
Promotions further strengthen management team. Brief article 262
Publicly held drug chains: their five-year track records. Table 1160
Regional structure serves 'grassroots company' well. 508
Reimbursement rates make physicians increasingly gun-shy. 370
Rein becomes chief executive at Walgreens. Brief article 245
Report on Rx errors draws fire. 955
Retail pharmacy braces for Medicaid cuts. 236
Retail pharmacy expected to outperform the economy. 1071
Retailer raises profile in West. 480
Retailers find new ways to connect with the customer. 404
Rite Aid is taking big leap ahead. 1453
Rite Aid makes most of 'unique opportunity'. Brief article 326
Rite Aid stays on front lines in battle against diabetes. 382
Rite Aid targets obesity epidemic. 707
Rite Aid, AHA team up in effort to prevent heart disease. Brief article 306
Rx drives Walgreens business. 379
Rx operators move to remake the market. Woldt, Jeffrey 732
Rx tackles public health problems. Polley, Cathy 937
RxSchool live online CE. Calendar 213
Ryan to Bush: Pharmacists get job done. Brief article 222
Sav-Mor makes most of part D. Company overview 1000
Schreiber slated to succeed Murphy at SDM. Brief article 226
Selective acquisitions are now part of the strategy. Brief article 181
Seniors can count on getting special attention. 345
Service is Ritzman's strength. Company overview 756
Sharper focus benefits longs. Company overview 987
ShopKo keeps hand in drug store sector. 452
Shoppers stimulated by upgraded stores. Company overview 901
Slow reimbursements hinder Rx. 324
Snyders prides itself on service. 574
Special events inform, entertain. Brief article 196
Store base realigned for growth. 407
Store brands hove yet to realize full potential. 542
Study predicts bigger government role. 355
Study: alliances can further R&D. Brief article 282
Supervalu hires Tripp to head Rx business. Brief article 228
Systems give pharmacists helping hand. 773
The first priority is maximizing productivity. 572
The hard work of transformation has begun'. Survey 675
The inkjet cartridge refilling market: positioned for growth. 1567
The times they are a- changin'. Industry overview 900
Thriftway/Zitomer knows its customers. Company overview 496
Thrifty white stays true to roots. Company overview 765
Top 100 pharmaceutical products *. Statistical table 716
Top 250 multisource generics. Statistical table 1877
Top 50 drug chains by dollar volume. Statistical table 565
Top 50 drug chains by store count. Company rankings 329
Torch passed from Bernauer to Rein. 671
Transaction demonstrates virtue of patience. Brief article 278
Two initiatives aim to streamline pivotal operations. 328
Two studies probe disease. Brief article 169
Uniprix makes alliance with Clinique Santo a winner. Company overview 911
USA Drug begins to take on higher profile. Company overview 659
Value drug mart makes provisions for long term. Company overview 871
Value, target marketing, bare-bones style prevail. Company overview 772
Wal-Mart accelerates $4 generics program. Brief article 232
Wal-Mart deepens health care commitment. 440
Walgreens plays the acquisition game--selectively. 846
Walgreens tabs Wasson president. 799
Walgreens' Bernauer briefs Senate panel. 238
Walgreens: 'a great company in a good business'. 782
Waxman aims to limit some D-T-C advertising. Brief article 250
With SDM in top form, Schreiber succeeds Murphy. Financial report 670
Zestra study offers insights on women's sexual health. Brief article 220

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters